HLA-DRA Back

major histocompatibility complex, class II, DR alpha

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of HLA-DRA

HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5.

Community Annotation of HLA-DRA Add / Edit HLA-DRA: Annotations

No community annotations yet for HLA-DRA.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

HLA-DRA is highly significantly mutated in
(none)
HLA-DRA is significantly mutated in
(none)
HLA-DRA is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for HLA-DRA